• Reliability, Validity and Responsiveness of A New Measure of Neck Disability (ND10)

    Oct 1, 2017, 00:00

  • Surgical Treatment Outcome of Lumbar Disc Herniation (LDH) In Different Ages

    Oct 1, 2017, 00:00

  • Burden Of Respiratory Syncytial Virus (RSV) Disease In Adults- Final Analysis From A Retrospective Chart Review

    Oct 1, 2017, 00:00

  • Clinical Characteristics Of Patients With Chronic Hepatitis C Infection At Initial Presentation To Tertiary Care In An Asian Middle-Income Country

    Oct 1, 2017, 00:00

  • Preferences of Parents To Avoid Oral Health Outcomes In Children- Results of A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Parametric Modelling of Migraine Day Frequency In Migraine Prevention- A Case Study Of Erenumab Clinical Trial Data

    Oct 1, 2017, 00:00

  • Patient Preferences for Interferon-Beta in Iran- A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Reliability And Validity Of The Mobility Section Of The Prosthesis Evaluation Questionnaire And Its Modified Version. Do They Measure The Same Construct?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Incobotulinumtoxin-A In The Longer-Term Management of Post-Stroke Spasticity of The Upper Limb

    Oct 1, 2017, 00:00

  • In What Sequence Do Companies Submit Health Technology Appraisal (HTA) Dossiers In The UK And Ireland, And In What Sequence Are They Published?

    Oct 1, 2017, 00:00

  • Internet Based Treatment of Depressive Symptoms – A Health Economic Evaluation of Costs and Benefits

    Oct 1, 2017, 00:00

  • The Economic Impact of Switching To Herceptin (TRASTUZUMAB) Biosimilar for The Treatment of Metastatic Breast Cancer From A UK Payer Perspective

    Oct 1, 2017, 00:00

  • Sensor Augmented Pum vs Multiple Daily Injections in Very Uncontrolled Diabetes Patients- Cost Model for Hypoglycemic Events, Imss Perspective

    Oct 1, 2017, 00:00

  • Clinical and Patient Reported Outcomes In Psoriatic Arthritis- A Narrative Review of The Literature

    Oct 1, 2017, 00:00

  • Medicine Prices Disparity Among Retail Pharmacies In Selangor, Malaysia

    Oct 1, 2017, 00:00

  • The Potential Value Of Real-World Evidence Along With Trial Efficacy To Estimate Effectiveness Of Novel Treatments In Real-World Setting; An Application With Overall Survival In Two Oncology Indications

    Oct 1, 2017, 00:00

  • Cost of Acute Myocardial Infarction in Colombia (2014)

    Oct 1, 2017, 00:00

  • Angiotensin II Receptor Blockers And Intestinal Malabsorption- An Observational Cohort Study In Germany And Italy

    Oct 1, 2017, 00:00

  • Healthcare Resource Utilization And Cost Of Patients With Acute Coronary Syndromes In Tianjin, China

    Oct 1, 2017, 00:00

  • Off-Label Drug Use In Hospitalized Children- A Prospective Observational Study At Gondar University Referral Hospital, Northwestern Ethiopia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Evaluation of a Care Bundle Intervention for Preventing Falls Among Italian Aged Inpatients in a Stepped-Wedge Cluster Randomized Controlled Trial

    Oct 1, 2017, 00:00

  • Measurement Of Multimorbidity To Predict All-Cause Mortality In A Nationwide Population, Using The French National Health Insurance Database (SNIIRAM)

    Oct 1, 2017, 00:00

  • Counterfactual Decomposition Of Health Care Expenditures- From Cost-Based Payment To Global Budget System

    Oct 1, 2017, 00:00

  • Pharmatool- An Economic and Epidemiological Calculation Tool To Aid Planning For Reducing Cardiovascular Morbidity In Brazil

    Oct 1, 2017, 00:00

  • Attitudes Towards Generic Substitution In Greece

    Oct 1, 2017, 00:00

  • The Associated Factors of Neuropathic Pain Among Chronic Low Back Pain Patients in South Korea- Findings from the NLBP OR

    Oct 1, 2017, 00:00

  • Efficacy and Safety of Interferon-Free Therapies For Chronic Hepatitis C Patients Coinfected With Hiv- Systematic Review of Clinical Trials

    Oct 1, 2017, 00:00

  • Health-Related Quality-Of-Life And Utility Measures Impact In A Randomized Controlled Study Of Fine Needle Aspiration Cytology (FNAC) Versus Watchful Observation In Patients With Incidental Symptomatic Thyroid Nodules

    Oct 1, 2017, 00:00

  • Patients Oriented Access Scheme- Learning From The Success Of The Israeli Innovative Solution For The Escalating Drugs Prices

    Oct 1, 2017, 00:00

  • Barriers To Access And Pricing Negotiations Criterial Selection For Novel Treatments For Hepatitis C In The Greek Healthcare Context

    Oct 1, 2017, 00:00

  • Recruiting Metastatic Patients into Non-Small Cell Lung Cancer Studies (NSCLC)- Lessons Learned from A Non-Interventional Study of NSCLC Patients with Central Nervous System (CNS) Metastases (METS) and Non-CNS Mets

    Oct 1, 2017, 00:00

  • The Economic Impact of Rheumatoid Arthritis on Patients’ Households. An Estimation of The Disease Related Catastrophic Health Expenditure, In Greece

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Quadrivalent Influenza Vaccine For National Immunization Program In South Korea

    Oct 1, 2017, 00:00

  • Cost and Treatment of Asthma and Copd in the Real Practi A Regional Segmentation

    Oct 1, 2017, 00:00

  • Cost Of Hospitalizations For Nontuberculous Mycobacterial Pulmonary Disease In France In 2014- A PMSI Database Analysis

    Oct 1, 2017, 00:00

  • Symptom Deterioration in Patients with Metastatic Renal Cell Carcinoma Treated with Cabozantinib or Everolimus

    Oct 1, 2017, 00:00

  • Costo-Efectividad De La Cirugía Bariátrica En Colombia

    Oct 1, 2017, 00:00

  • Modeling Covariate-Adjusted Survival for Economic Evaluations in Oncology

    Oct 1, 2017, 00:00

  • Public Health And Economic Benefits Of Quadrivalent Influenza Vaccine In Mexico

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Interferon-Free Treatment Strategies For Hepatitis C After Generic Entry Of Direct-Acting Antivirals In The Kazakhstan

    Oct 1, 2017, 00:00

  • Health State Utilities Associated with Treatment Options for Acute Myeloid Leukemia (AML)

    Oct 1, 2017, 00:00

  • Treatment Cost of Hepatocellular Carcinoma from The Health Insurance’s Perspective in Viet Nam

    Oct 1, 2017, 00:00

  • Using Observational Data From Registry In Cost-Effectiveness Evaluation of Metastatic Castration Resistant Prostate Cancer In France

    Oct 1, 2017, 00:00

  • Evaluation of The Long-Term Cost-Effectiveness Of Real Time Continuous Glucose Monitoring (RTCGM) Versus Self Monitoring Of Blood Glucose (SMBG) Alone In Type 1 Diabetes From The Swedish Societal Perspective

    Oct 1, 2017, 00:00

  • Great Saphenous Vein Radiofrequency Ablation Versus Standard Stripping in The Management of Primary Varicose Veins- Economic Evaluation Into the Mexican Context

    Oct 1, 2017, 00:00

  • Treatment Sequencing for Patients With Multiple Myeloma with at Least One Prior Line- Comparing Progression-Free Survival and Costs Under a Private Payer Perspective

    Oct 1, 2017, 00:00

  • Experiences With Price Competition Of Biosimilar Drugs In Hungary

    Oct 1, 2017, 00:00

  • Impact Of Genomic Testing Billing Practices On Utilization In Academic Hybrid Oncology Practice

    Oct 1, 2017, 00:00

  • Analysis of The Budget Impact of Secukinumab use Versus Anti-Tnf Agents in Ankylosing Spondylitis Patients

    Oct 1, 2017, 00:00

  • Review Of Reimbursement Decision Drivers For Rare Cancer Therapies Across EU5 Markets

    Oct 1, 2017, 00:00

  • Evaltuation of The National Drug Formularium and Electronic Catalog For The Indonesian UHC

    Oct 1, 2017, 00:00

  • The Cost Of Treating Diabetic Ketoacidosis In The UK- A National Survey Of Hospital Resource Use

    Oct 1, 2017, 00:00

  • Health Care Use Among Incident Cases of Heart Failure- A Population-Based Cohort Study from 1997 To 2010

    Oct 1, 2017, 00:00

  • Racial Disparities in Treatment of Pregnant Women with Drug Use, Abuse and Dependence

    Oct 1, 2017, 00:00

  • Efficacy of Indacaterol/Glycopyrronium in Chronic Obstructive Pulmonary Disease- Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Easypod™ Device Versus Other Somatotropin Delivery Techniques In Egypt In Treatment of Growth Hormone Deficiency

    Oct 1, 2017, 00:00

  • Evaluating Matching-Adjusted Indirect Comparison and Simulated Treatment Comparison Techniques- Impact on Health-Related Quality of Life of Focussed Ultrasound Thalamotomy and Other Interventions for the Treatment of Medication-Refractory E ...

    Oct 1, 2017, 00:00

  • Identifying the Challenges to Adult Influenza Vaccination in Latin America

    Oct 1, 2017, 00:00

  • Evaluating Patients’ Preferences for Dulaglutide Versus Insulin Glargine Profiles in the United Kingdom- A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Evaluation of Appropriateness of Antibiotics in the Intensive Care Unit of a Tertiary Care Hospital

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Levetiracetam for Patients With Juvenile Myoclonic Epilepsy- A Modeling Approach By The Brazilian Public Health Care System Perspective

    Oct 1, 2017, 00:00

  • Biologic Uptake Trends In Rheumatoid Arthritis

    Oct 1, 2017, 00:00

  • Could Healthcoin Be A Revolution In Healthcare?

    Oct 1, 2017, 00:00

  • Análise De Impacto Orçamentário Do Axitinibe Na Segunda Linha De Tratamento Do Carcinoma De Células Renais Metastático Sob a Perspectiva Do Sistema Privado De Saúde Brasileiro

    Oct 1, 2017, 00:00

  • Price Comparison Of New Drugs In Japan, Eu And Us

    Oct 1, 2017, 00:00

  • Resource Utilisation And Related Health Care Costs Among Patients With Multiple Myeloma With ≥ 2 Prior Lines Of Treatment In Finland- Evaluation Based On Finnish Real World Data From Auria Biobank

    Oct 1, 2017, 00:00

  • Cost-Comparison Between the Etonogestrel Implant and the Medroxyprogesterone Acetate Injectable- Number of Unintended Pregnancies and Financial Impact

    Oct 1, 2017, 00:00

  • An Economic Model To Support Decisions on The Adoption of Multivalent Vaccination Against Infectious Causes of Reproductive Disorders in Brazilian Cow-Calf Beef Herds Using Artificial Insemination

    Oct 1, 2017, 00:00

  • Systematic Review of The Cost-Effectiveness of Medicines For The Treatment of Idiopathic Pulmonary Fibrosis

    Oct 1, 2017, 00:00

  • Recent Trends in Provider Perceptions and Use of Value Frameworks in the United States (US)

    Oct 1, 2017, 00:00

  • An Algorithm To Develop Correlated Multivariate Non-Normal (E.G. Beta, Gamma, Log-Normal) Distributions To Be Used In Probabilistic Sensitivity Analyses (PSAS)

    Oct 1, 2017, 00:00

  • Initiatives That Impact Pricing And Reimbursement of Orphan (AND ULTRA ORPHAN) Drugs- Review of European Trends

    Oct 1, 2017, 00:00

  • Stakeholder Perspectives On The Integration Of Patient Preferences In The Medical Product Life Cycle- A Multimethod Approach

    Oct 1, 2017, 00:00

  • Relevance Of Real World Data In German Amnog Submissions In Oncology

    Oct 1, 2017, 00:00

  • Validity of Change In Recall Period For The Norfolk QOL Patient Reported Outcome (PRO) Measure

    Oct 1, 2017, 00:00

  • Patient Experience Assessments in Advanced Gastric, Esophageal, and Gastroesophageal Junction Cancer Studies

    Oct 1, 2017, 00:00

  • Secukinumab Provides Higher Symptomatic Improvement Versus Adalimumab in Psoriatic Arthritis- Comparative Effectiveness Up to 48 Weeks Assessed by two Matching-Adjusted indirect Comparisons

    Oct 1, 2017, 00:00

  • Custo De Tratamento Biológico Em Pacientes Com Doenças Reumáticas Em Uma Operadora De Saúde De Fortaleza/Ce

    Oct 1, 2017, 00:00

  • Assessing the Economic and Humanistic Burden of Psoriatic Arthritis in Brazil

    Oct 1, 2017, 00:00

  • Evaluation of The Clinical Effectiveness of Axitinib, Cabozantinib, Everolimus, Nivolumab, Sunitinib And Best Supportive Care (BSC) In Previously Treated Advanced or Metastatic Renal Cell Carcinoma (AMRCC)- A Systematic Review And Mixed-Tre ...

    Oct 1, 2017, 00:00

  • Impact of a Community Pharmacy-Based Information Program on Type 2 Diabetic Patients’ Adheren Iphodia, a Cluster Randomized Study VS Usual Practice - 12 Month Final Results

    Oct 1, 2017, 00:00

  • Comparative Analysis Of Health Technology Assessments Of Drugs For The Treatment Of Multiple Myeloma

    Oct 1, 2017, 00:00

  • The Choice of Effectiveness Criteria Affects Conclusions of Economic Evaluation of Health Care Innovations- Example Based on A Randomised Multicenter Trial Comparing Two Reduced Intensity Conditioning Regimen (FLU-BU-ATG) Vs. (FLU-TBI) For ...

    Oct 1, 2017, 00:00

  • Secukinumab vs Adalimumab for The Treatment of Ankylosing Spondylitis- A Cost Per Responder Analysis at 52 Weeks from A Brazilian Perspective

    Oct 1, 2017, 00:00

  • Easipro3 – Enhancing Satisfaction With Prostate Cancer Treatment Decision With The Mobile Health Program Prostana- A Multicenter Randomized Controlled Trial

    Oct 1, 2017, 00:00

  • Does The Study Population And The Use Of Proxy Respondent Have An Effect On The Latent Quality Of Life Constructs Measured By The CHU9D And The Pedsqltm 4.0? An Exploratory Factor Analysis

    Oct 1, 2017, 00:00

  • Does Access To Highly Specialised Medicines Decline In A Northerly Direction?

    Oct 1, 2017, 00:00

  • Evaluating Access To Treatment- A Comparison of The Expected Number of Patients with Metastatic Colorectal Cancer (Mcrc) To Those Effectively Treated in The Brazilian Public Healthcare System

    Oct 1, 2017, 00:00

  • Secukinumab Vs Adalimumab for the Treatment of Ankylosing Spondilytis- A Cost Per Responder Analysis at 52 Weeks from a Moroccan Perspective

    Oct 1, 2017, 00:00

  • Analysis Of Health-Related Quality Of Life (HRQOL), And Costs Of Treatment In Chronic Myelogenic Leukemia (CML) In Bulgaria

    Oct 1, 2017, 00:00

  • The Cost Of Illness For Invasive Meningococcal B Disease In Germany

    Oct 1, 2017, 00:00

  • Adequacy of Glycemic Control in Greek Patients with Type 2 Diabetes Mellitus Treated with Metformin Monotherapy at the Maximum Tolerated Dose- The Reload Study

    Oct 1, 2017, 00:00

  • Productivity Costs Related to Bortezomib And Carfilzomib Administration For Multiple Myeloma In Finland

    Oct 1, 2017, 00:00

  • Landscape Of Reported Drug Shortages In European Countries

    Oct 1, 2017, 00:00

  • Evaluation Of Patient- (PRO) And Observer-Reported Outcomes (OBSRO) Measures Regarding Acceptability And Palatability Of Eltrombopag In A Pediatric Population

    Oct 1, 2017, 00:00

  • Health-Related Quality Of Life And Pharmacotherapy Costs Study For Patients With Rare Endocrine Diseases In Bulgaria – A Pilot Study

    Oct 1, 2017, 00:00

  • Analysis of Clinical And Economic Effectiveness of Statins For Secondary Prevention of Cardiovascular Disease In Kazakhstan

    Oct 1, 2017, 00:00

  • Examination Of Adherency Of High-Risk Pregnant Women With Gestational Diabetes Mellitus Care Especially With Respect To Diet And Physical Activity

    Oct 1, 2017, 00:00

  • The Novel Generation And Validation of Survival Curves In Oncology Utilizing Electronic Medical Records Linked To Point of Service Claims Data

    Oct 1, 2017, 00:00

  • Treatment Patterns and Satisfaction For Rheumatoid Arthritis Patients In Latin America Undergoing Advanced Therapy

    Oct 1, 2017, 00:00

  • Continuous Subcutaneous Infusion Versus Multiple Dose Injection of Insulin For Newly-Diagnosed T1D Paediatric Patients- A Cost-Utility Analysis

    Oct 1, 2017, 00:00

  • Healthcare Professionals’ Preferences for the Treatment Selection of Chronic Lymphocytic Leukemia (CLL)- The Prelic Study

    Oct 1, 2017, 00:00

  • Pricing Regulation In Greece - Analyzing The Price Bulletin Of December 2016

    Oct 1, 2017, 00:00

  • Cost Effective Analysis Of Pharmaceutical Care In Management Of Patients With Stage Iii Hypertension- An Indian Pharmacists Experience

    Oct 1, 2017, 00:00

  • Influenza Vaccination Among Pregnant Women- Exploratory Analysis From The 2012-2015 National Health Interview Survey

    Oct 1, 2017, 00:00

  • Impacto De Una Ley De Bioequivalencia En El Precio De Medicamentos

    Oct 1, 2017, 00:00

  • What Can Be Done for Access and Reimbursement Processes To Reward Innovation In Digital “Beyond The Pill” Solutions?

    Oct 1, 2017, 00:00

  • Assessment Of Hypertension Patients’ Adherence In Bulgaria – Pilot Study

    Oct 1, 2017, 00:00

  • Economic Analysis of The Use of Non-Invasive Prenatal Test (NIPT) For Prenatal Screening of Trisomy 21, 18, 13 In Pregnant Women

    Oct 1, 2017, 00:00

  • Long-Term Benefits of LDL Cholesterol Lowering In Young Adulthood- A Computer Simulation Study

    Oct 1, 2017, 00:00

  • A Comparative Analysis Of The Health Care Utilization And Costs Of Patients Diagnosed With And Without Liver Cancer In The US Medicare Population

    Oct 1, 2017, 00:00

  • Quantifying the Trade-off Between Improved Glycemic Control and Severe Hypoglycemia Risk in Patients with Type 1 Diabetes- A Health Economic Analysis in the Uk

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analisys of Ixabepilone Monotherapy in Patients with Advanced or Metastatic Breast Cancer Resistant To Anthracyclines, Taxanes and Capecitabine

    Oct 1, 2017, 00:00

  • Leveraging Electronic Health Records to Meet The Real World Evidence Needs of Hta- A Uk Perspective

    Oct 1, 2017, 00:00

  • Insertable Cardiac Monitor Versus Standard of Care For Detection Of Atrial Fibrillation In Patients Following Cryptogenic Stroke- A Dutch Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Economic and Clinical Impact of Serum-Derived Bovine Immunoglobulin / Protein Isolate (SBI) in the Management of Chronic Diarrhea in Inflammatory Bowel Disease (IBD)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Alemtuzumab In Comparison With Natalizumab, Intramuscular Interferon Beta-1a, Subcutaneous Interferon Beta-1b, And Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis In Iran

    Oct 1, 2017, 00:00

  • Uses and Applications of Eq-5d in Latin America the Caribbean- Systematic Review and Bibliometric Analysis

    Oct 1, 2017, 00:00

  • A Minimally Invasive Hemodynamic Monitoring Device for the Brazilian Health System- Is Flotrac® Cost-Effective?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Bezlotoxumab + Standard Of Care (SOC) Versus Placebo + Soc For The Prevention Of Recurrent Clostridium Difficile Infection In The United Kingdom

    Oct 1, 2017, 00:00

  • Overview Of Innovative Medicine Sector In Turkey

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of IVF Treatments Gonal-F® Versus HP-HMG in the United Arab Emirates (UAE)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness and Modeling Approaches of Direct-Acting Antiviral Agents In Chronic Hepatitis C Infection- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Key Drivers In Health Technology Assessment By Analysing The Level Of Improvement In Actual Benefit In Solid Tumor Oncology Drugs

    Oct 1, 2017, 00:00

  • The Use of The Propensity Score In The Cost-Effectiveness Analysis of The Atrial Fibrillation Treatment

    Oct 1, 2017, 00:00

  • Characterization Of Low Density Lipoprotein (LDL) Levels In Patients Diagnosed With Arterial Hypertension In Colombian Population In The Year 2016

    Oct 1, 2017, 00:00

  • The Impact of Trial Design on Network Meta-Analysis and Decision-Making- A Working Example in Ulcerative Colitis

    Oct 1, 2017, 00:00

  • Pharmaceutical Care Workload And Workforce Requirement At Ministry Of Health Primary Care Centers During Ten Years Mass Gathering Hajj (2006-2015) In Makah Regions, Saudi Arabia

    Oct 1, 2017, 00:00

  • Comparative Effectiveness Of Novel Treatments For Advanced Melanoma- A Systematic Literature Review And Network Meta-Analysis Of Effectiveness And Safety Outcomes

    Oct 1, 2017, 00:00

  • Issues Encountered When Modelling The Long Term Clinical Effectiveness Of Treatments From Short Term Trials Using Second-Line Treatments For Advanced Or Metastatic Renal Cell Carcinoma (AMRCC) As An Example

    Oct 1, 2017, 00:00

  • Clinical And Economic Benefit Of Upper Airway Stimulation For Obstructive Sleep Apnea In The German Setting

    Oct 1, 2017, 00:00

  • Exploring Factors Explaining Treatment Acceptance in Patients Suffering from a Chronic Disease

    Oct 1, 2017, 00:00

  • Biosimilars And Reference Biotechnologic Drugs- Comparison Of The Biosimilars’ Effect On Reference Drug’s Price For EU, USA And Turkey

    Oct 1, 2017, 00:00

  • Patterns of Estimated Glomerular Filtration Rate and Albuminuria in Relation to Progression to Serious Outcomes- Hospitalization for Infection, Major Adverse Cardiovascular Events and Renal Failure

    Oct 1, 2017, 00:00

  • A Comparison of Health Technology Assessment (HTA) Requirements For Systematic Literature Reviews (SLRS)

    Oct 1, 2017, 00:00

  • Risk Factors of Asthma and Their Role in Triggering The Asthmatic Attack

    Oct 1, 2017, 00:00

  • A Population-Based Study on Clinical Outcomes and Medical Costs of Laparoscopic Versus Open Surgery for Colon Cancer Patients in Taiwan

    Oct 1, 2017, 00:00

  • Comparison Of Costs Between Hospital And Home Infusions In Patients Treated With Laronidase

    Oct 1, 2017, 00:00

  • Reduced Needlestick Injuries And HBV Infections In Chinese Healthcare Workers From Blunt-Tip Suture Needles In Cesarean Sections- A Markov Simulation

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Ulinastatin for Patients Undergoing Hepatectomy- A Discrete Event Simulation Model

    Oct 1, 2017, 00:00

  • Persistence and Adherence to Oral Antiresorptive Therapy in a Fracture Liaison Servi 24-Month Results of a Prospective Cohort Study

    Oct 1, 2017, 00:00

  • Treatment in Transplant Eligible Multiple Myeloma Patients in Macedonia- Development of Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Unmet Pharmaceutical Needs During The Economic Crisis In Greece

    Oct 1, 2017, 00:00

  • Long-Term Impact of Grass-Pollen (GP) Sublingual Immunotherapy Tablet (SLIT) on Allergic Rhinitis (AR) and on Allergic Asthma (AA) Onset and Progression

    Oct 1, 2017, 00:00

  • Development of a Screening Questionnaire to Detect Heavy Menstrual Bleeding in Women of Child-Bearing Age

    Oct 1, 2017, 00:00

  • Positive Externalities of austerity? The Case of Smoking Cessation During the Financial Crisis in Greece

    Oct 1, 2017, 00:00

  • Extrapolation of Adult Data for Pediatric Drug Benefit Assessment In The Amnog Dossier In The Light of The New Amvsg

    Oct 1, 2017, 00:00

  • A Systematic Review To Evaluate The Association Between Medication Adherence And Personality Traits

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Continuous Versus Intermittent Celecoxib Use for HIP and Knee Osteoarthritis

    Oct 1, 2017, 00:00

  • Real World Data on Multiple Myeloma Treatment Patterns- First and Second-Line Treatment in the Brazilian Public Health System

    Oct 1, 2017, 00:00

  • Budget Impact of Introducing Secukinumab In The Treatment of Moderate-To-Severe Plaque Psoriasis From The Private Payer Perspective In Brazil

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Tapentadol Prolonged Release Versus Oxycodone Controlled Release In The First-Line Treatment of Moderate To Severe Chronic Pain Under The Perspective of The Colombian Subsidized Public Healthcare System

    Oct 1, 2017, 00:00

  • Systematic Literature Review And Indirect Comparison of Glasdegib Plus Low Dose ARA-C Versus A Hypomethylating Agent For Acute Myeloid Leukemia Patients Ineligible For Intensive Chemotherapy

    Oct 1, 2017, 00:00

  • A Cost Effectiveness Analysis Of Seasonal Quadrivalent Influenza Vaccine In Italy Using A Static Model

    Oct 1, 2017, 00:00

  • Pro Instruments used in Studies of Pulmonary Hypertension Since 1960

    Oct 1, 2017, 00:00

  • Secukinumab is Dominant Vs. TNF-Inhibitors in the Treatment of Active Ankylosing Spondylitis- Results from a Turkish Cost-Effectiveness Model

    Oct 1, 2017, 00:00

  • Comparisons Of Healthcare Utilization And Cost Impact Of Managing Type 2 Diabetes Across The System Of Care In Medicare Beneficiaries

    Oct 1, 2017, 00:00

  • Oral Estrogen Therapy Is Associated With Reduced Risk of Hepatitis B Virus–Related Hepatoma In Taiwanese Postmenopausal Women

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Pembrolizumab for The First-Line Treatment of Metastatic Non-Small Cell Lung Carcinoma in Portugal

    Oct 1, 2017, 00:00

  • Reliability And Validity Of Two Proxy Versions Of EQ-5D-5L In Japan

    Oct 1, 2017, 00:00

  • Estimation of The Cost of Metastatic Melanoma in France Using Melbase Data

    Oct 1, 2017, 00:00

  • Factors Contributing to the Ceiling Effect Among Patients with Prostate Cancer who Were Judged to Have “Full-Health” by EQ-5D-5L

    Oct 1, 2017, 00:00

  • Improving Disease Detection Through Methods To Reduce Patient Heterogeneity

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Cobicistat-Boosted Darunavir In Hiv-Infected Patients In Mexico

    Oct 1, 2017, 00:00

  • The Economic Impact Of Providing Dengue Vaccination In The Workplace In Brazil

    Oct 1, 2017, 00:00

  • Systematic Literature Review of the Impact of Asthma Support Programs Dedicated to Adult Patients

    Oct 1, 2017, 00:00

  • The Cystic Fibrosis Impact Questionnaire (CF-IQ)- Qualitative Development And Cognitive Evaluation Of A New Patient-Reported Outcome Instrument To Assess The Life Impacts Of Cystic Fibrosis

    Oct 1, 2017, 00:00

  • Risk Factors Associated With Tuberculosis In Punjab, Pakistan

    Oct 1, 2017, 00:00

  • Integrated Care System For Hypertension In China- What The Cost Will Be For Government? A budget impact analysis

    Oct 1, 2017, 00:00

  • Analysis Of The Behavior Of The Expenditure Curve In Oncology And Other Causes Of Death In The Last 5 Years Of Life – Brazil Real-World Health Care Data

    Oct 1, 2017, 00:00

  • Reporting Of The Use Of Research And Publication Guidelines In Health Economic And Outcomes Research Publications In Inflammatory Bowel Disease – A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Development Of A Descriptive System For Measuring Patient Experience

    Oct 1, 2017, 00:00

  • Obstructive Sleep Apnea Treatment Guidelines - Implementation Status In Oecd-Countries

    Oct 1, 2017, 00:00

  • Increased Episode Rate of Medically-Attended Acute Gastroenteritis In Diabetics In England

    Oct 1, 2017, 00:00

  • The Use of Real World Data for Nice Decision-Making- A Review of Submissions To Three Treatment Effectiveness Evaluation Programmes In 2015 And 2016

    Oct 1, 2017, 00:00

  • Orphan Drugs In The Uk, Do They Meet The Nice Highly Specialised Technology Threshold?

    Oct 1, 2017, 00:00

  • Healthcare Costs Associated with Cervical Cancer, Precancerous Lesions, and Genital Warts Treatment in Taiwan

    Oct 1, 2017, 00:00

  • The Need For Developing A Decision Aid Tool About Feeding Options

    Oct 1, 2017, 00:00

  • Costo Efectividad Del USO De Ticagrelor Frente A Copidogrel En Pacientes CON Síndrome Coronario Agudo En Colombia

    Oct 1, 2017, 00:00

  • The Clinical and Cost-Effectiveness of Different Maternal Syphilis Screening Strategies in Brazil

    Oct 1, 2017, 00:00

  • Economic Evaluation of Romiplostim Vs Eltrombopag In The Treatment of Adult Patients With Chronic Immune Thrombocytopenia In Mexico

    Oct 1, 2017, 00:00

  • The Examination Of Location And Frequency Of Pain In Weight Training

    Oct 1, 2017, 00:00

  • Literature Review of The Cost of Dementia on China

    Oct 1, 2017, 00:00

  • The Impact of Beliefs Towards Illness and Medications on Adherence and Clinical Outcomes in Acute Coronary Syndrome Patients in Hong Kong

    Oct 1, 2017, 00:00

  • External Validation of A Mapping Algorithm To Estimate Eq-5d-3l Utilities From Oxford Knee Score Responses

    Oct 1, 2017, 00:00

  • A Systematic Review Of Calibration In Population Models

    Oct 1, 2017, 00:00

  • Analysis Of Epidemiological Data On Burden Disease In Europe

    Oct 1, 2017, 00:00

  • Force Of Infection Of Helicobacter Pylori In Mexico- Evidence From A National Survey

    Oct 1, 2017, 00:00

  • A Healthcare Policy Study To Build A Roadmap for Rare Disease Management Under The Egyptian Healthcare System

    Oct 1, 2017, 00:00

  • Retrospective Analysis of the Use of Incremental Cost-Effectiveness Ratio (Icer) in Technology Incorporation in the Brazilian Public Health System (Sus), 2012-2016, Perspectives and Challenges for the Brazilian Context

    Oct 1, 2017, 00:00

  • Seal or Varnish? Cost-Effectiveness of Fissure Sealants Versus Fluoride Varnish in Preventing Dental Decay in Children

    Oct 1, 2017, 00:00

  • Cambio En La Carga De Enfermedad Ajustada Por Riesgo Para Una Población Afiliada A UNA Aseguradora Colombiana

    Oct 1, 2017, 00:00

  • Overall Survival In Patients With Metastatic Urothelial Cancer By First-Line Therapy

    Oct 1, 2017, 00:00

  • Evaluating The Addition To Formulary of Belimumab For The Treatment of Systemic Lupus Erythematosus- A Cost-Effectiveness Model

    Oct 1, 2017, 00:00

  • A Conceptual Model For Pediatric Gastroesophageal Reflux

    Oct 1, 2017, 00:00

  • Eating Habits and Physical Exercise Practices of Beneficiaries and Non-Beneficiaries of Private Health Plans In Brazil

    Oct 1, 2017, 00:00

  • Risk of Dipeptidyl-Peptidase-4 (Dpp-4) Inhibitors On Site-Specific Cancer- A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00

  • Consistency Assessment of International Drug Price Comparisons

    Oct 1, 2017, 00:00

  • Burden of Hospitalizations Related To Spinal Tumors in Fran Evolution Between 2012 and 2014

    Oct 1, 2017, 00:00

  • Estimation of the Additional Budget Saving Potential Due to the Rapid Adoption of An Etanercept Biosimilar (SB4) for the Treatment of Approved Adult Etanercept Indications in Spain

    Oct 1, 2017, 00:00

  • An Observational Retrospective Cohort Database Study To Estimate Costs Regarding Immunoglobulin Use for Itp Treatment In The Brazilian Public Healthcare System

    Oct 1, 2017, 00:00

  • Social Burden of Copd

    Oct 1, 2017, 00:00

  • To Determine The Financial Imapct of Introducing Sc Rituximab (MABTHERA) vs. Currently used iv rituximab (MABTHERA) on The Budgets of Different Hospitals Across The Kingdom of Saudi Arabia (KSA)

    Oct 1, 2017, 00:00

  • Real-World Resource Use And Costs of Carcinoid Heart Disease In Patients With Neuroendocrine Tumors- A Retrospective Swedish Study

    Oct 1, 2017, 00:00

  • Statistics and Costs of Emergency Care Related to External Causes in One Hospital of Rio De Janeiro City

    Oct 1, 2017, 00:00

  • Estimating Survival After Radical Prostatectomy In Prostate Cancer; A Propensity-Score Matching Method

    Oct 1, 2017, 00:00

  • Antineoplásicos De Maior Impacto Financeiro No Instituto Nacional De Cancer Do Brasil

    Oct 1, 2017, 00:00

  • When The Price Is Right- When, In Practice, Are Confidential Discounts Introduced In The Nice Process?

    Oct 1, 2017, 00:00

  • Supporting Individual Reflection and Patient-Clinician Shared Decision-Making on GEP-NET Management Options Using Reflective Multi-Criteria Decision Analysis

    Oct 1, 2017, 00:00

  • Programa Stewardship- Otimizando A Terapia Antimicrobiana Com Eficiência Em Um Hospital De Ensino De Referência Em Fortaleza, Ceará

    Oct 1, 2017, 00:00

  • A Retrospective Premier Database Study To Compare Repair of Ventral Hernia With Phasixtm VS Stratticetm In The Inpatient Hospital Surgical Setting

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Peginterferon Beta-1a Vs. First-Line Injectable Disease-Modifying Therapies For The Treatment of Relapsing-Remitting Multiple Sclerosis In Spain

    Oct 1, 2017, 00:00

  • Real-World Multiple Myeloma Treatment Pattern In Morocco- Evidence From Patient Chart Audit

    Oct 1, 2017, 00:00

  • Primary Nonadheren Do Differences Exist Between Life Sustaining And Quality Of Life Medications?

    Oct 1, 2017, 00:00

  • Mechanisms Of Trade Margin Regulation Of Prescription Drugs- Comparison Of 15 Eu Countries

    Oct 1, 2017, 00:00

  • Relative Value of Evidem Mcda Framework for Reflective Drug Evaluation Among Therapeutic Positioning Report Evaluators From The Spanish Agency of Medicines

    Oct 1, 2017, 00:00

  • A Budget Impact Analysis of Fidaxomicin Versus Vancomycin and Metronidazole for the Treatment of Clostridium Difficile

    Oct 1, 2017, 00:00

  • Length of Trial Period and Fit of Standard Survival Extrapolation Distributions for Ipilimumab in Melanoma

    Oct 1, 2017, 00:00

  • Comparison of Secukinumab Vs Infliximab in a Cost Per Responder Analysis Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Psoriatic Arthrisis at 48 Weeks from a Moroccan Perspective

    Oct 1, 2017, 00:00

  • Pharmacoeconomics Analysis of Sertindole Use In The Treatment of Schizophrenia In Russia

    Oct 1, 2017, 00:00

  • Potential Funding Sources For Breakthrough Therapies

    Oct 1, 2017, 00:00

  • Evaluating Health Impact Of Common Chronic Conditions On Quality Of Life Of EQ-5D-3L In Older Chinese

    Oct 1, 2017, 00:00

  • 90-Day Mortality And Its Predictors In Men With Contralateral Hip Fracture After Femoral Neck Fracture

    Oct 1, 2017, 00:00

  • Drug-Safety Program Impact In The Emergency Frequency At Patients With Persistent Severe Asthma

    Oct 1, 2017, 00:00

  • Assessing Racial Disparity In Palliative Care Consultation And The Impact Of Palliative Care Consultation On Hospi A Multi-Hospital Analysis

    Oct 1, 2017, 00:00

  • Copyright/Subscription

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life, Work Productivity And Activity Impairment Associated With Clostridium Difficile Infection In China, Brazil, Europe and The United States

    Oct 1, 2017, 00:00

  • Quality of Life for Patients with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas (PNF)

    Oct 1, 2017, 00:00

  • Can Early Access Support Continued Access? The Relationship Between Eams And Nice

    Oct 1, 2017, 00:00

  • Multivariate Network Meta-Analysis of Survival Function Parameters

    Oct 1, 2017, 00:00

  • Analysis of Drug Utilisation Data Sources to Enable Nationwide Value-Based Pricing of Medicines Across Healthcare Systems in Europe

    Oct 1, 2017, 00:00

  • Bayesian Methodology Considering Historical Data To Predict Overall Survival From Immature Trial Data In Oncology

    Oct 1, 2017, 00:00

  • Incidence of Non-Small-Cell Lung Cancer And Burden of Egfr Mutations- A 10-Year Global Forecast

    Oct 1, 2017, 00:00

  • Factors Affecting Polypharmacy in Elderly Patients with Diabetes in Greece

    Oct 1, 2017, 00:00

  • Expected Value of Information Analysis to Evaluate the Potential Gains of an RCT Comparing Wound Dressings

    Oct 1, 2017, 00:00

  • Model Attention Improve The Hospital Nutrition Processes Under The Center Of Excellence Concept

    Oct 1, 2017, 00:00

  • Evaluation of the Cost Saving Potential of Introducing an Etanercept Biosimilar (SB4) for the Treatment of Approved Etanercept Indications in the Republic of Ireland

    Oct 1, 2017, 00:00

  • Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Patients with Relapsed or Refractory Multiple Myeloma

    Oct 1, 2017, 00:00

  • Health Economic Analysis Of Pneumococcal Conjugated Vaccines For Mexico, Under A Technical Parity Scenario

    Oct 1, 2017, 00:00

  • Burden of Disease for Rheumatoid Arthritis In Argentina, Brazil, Colombia, Mexico and Venezuela

    Oct 1, 2017, 00:00

  • Rasch Measurement Analysis Of The Lower Extremity Functional Scale For Foot And Ankle Patients

    Oct 1, 2017, 00:00

  • Economic Evaluations of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain- A Systematic Review

    Oct 1, 2017, 00:00

  • Embedding Randomized Controlled Trials into Medical Practice

    Oct 1, 2017, 00:00

  • Influência Dos Fatores Socioeconômicos Na Incidência De Câncer De Mama- Revisão Sistemática

    Oct 1, 2017, 00:00

  • Orphan Drugs In Fran Key Market Access Incentives

    Oct 1, 2017, 00:00

  • Prescription Analysis on Off-Label Drugs In Pediatric Patients Using The Claims Data of The National Health Insurance In Korea

    Oct 1, 2017, 00:00

  • Modelling The Societal Impact Of Alirocumab In Patients With Severe Hypercholesterolemia Treated With Apheresis In Germany

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analysis of Using Solifenacin And Modified-Release Tamsulosin Fixed Dose Combination for Treatment of Storage Symptoms Associated With Benign Prostatic Hyperplasia

    Oct 1, 2017, 00:00

  • Adapting The United States’ Antimicrobial Stewardship Programme Guidelines To Build An Economic Evaluation Framework For Chinese Hospitals

    Oct 1, 2017, 00:00

  • The Role of Stakeholder Engagement in E-Health and the use of Big Data to Predict Health Outcomes

    Oct 1, 2017, 00:00

  • Delaying Second Line Diabetes Treatment Onset In Patients Uncontrolled With Metformin Xr In Saudi Arabia- Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Treatment Patterns Among Newly Diagnosed Diabetes Patients in Dubai

    Oct 1, 2017, 00:00

  • Characteristics and cost burden of adverse drug reactions in a tertiary health care hospital in southern chile

    Oct 1, 2017, 00:00

  • Comparing Quality of Life of (RT-PA) with No-(RT-PA) in Stroke Attacked Patients

    Oct 1, 2017, 00:00

  • Economic Evaluation And Cost-Effectiveness Threshold In Practice Of Decision-Making On Orphan Drug Reimbursement In Poland

    Oct 1, 2017, 00:00

  • Analysis of Oral Hypoglycemic Drugs Consumption in Ukraine in 2015

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Daclizumab Beta Vs Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis Patients With Inadequate Response To Prior Treatment In Scotland

    Oct 1, 2017, 00:00

  • Special Considerations for Conducting Qualitative Interviews With Cancer Patients and Their Caregivers for The Purpose of Developing Clinical Outcome Assessments

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of A Point-Of-Care Test For Renal Function Measurement In Community Pharmacies In The Netherlands To Prevent Antibiotic-Related Hospitalizations

    Oct 1, 2017, 00:00

  • Cost Effectiveness Of Pentaray High Density Mapping Catheter In Treatment Of Ventricular Tachycardia In Turkey

    Oct 1, 2017, 00:00

  • Cost-Minimization Analysis Of HPV 16/18 Genotyping Test Versus HPV Reflex Genotyping For Cervical Cancer Screening

    Oct 1, 2017, 00:00

  • Integrated 2 Screw De-Rotation/Compression, Cepahlo-Medulary Device Reduces Implant Related Complications and Improves Health Related Quality of Life in Patients with Intertrochanteric Fractures, A Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Ixekizumab Treatment Leads to Early Resolution of Bothersome Symptoms Versus Ustekinumab

    Oct 1, 2017, 00:00

  • Cost Impact Analysis of Needlestick Injuries In India

    Oct 1, 2017, 00:00

  • The Impact of Health Policy on The Pharmaceutical Supply Chain In France

    Oct 1, 2017, 00:00

  • Antibiotic Stewardship Policy in Biella General Hospital (Italy)- A Five-Year Surveillance

    Oct 1, 2017, 00:00

  • The Impact of Managed Entry Agreements on Drug Time to Market in Italy

    Oct 1, 2017, 00:00

  • Prevalence of Cardiovascular Disease In Type 2 Diabetes- A Global Systematic Review

    Oct 1, 2017, 00:00

  • Cost Of Treatment-Related Adverse Events (TRAES) In Second-Line (2l) Advanced Hepatocellular Carcinoma (AHCC)- Match Adjusted Indirect Comparison (MAIC) Of Nivolumab And Regorafenib

    Oct 1, 2017, 00:00

  • Transfusion Trends In Primary and Revision Total Joint Arthroplasty- Are Recent Declines Shared Equally?

    Oct 1, 2017, 00:00

  • Considerations for The Selection of Written Chinese Variants In The Process of Translating and Linguistically Validating Clinical Outcome Assessments (COAS)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Comparison of Opoid Substitution Therapy Vs. Non-Pharmcologic Therapy In The State of Kuwait

    Oct 1, 2017, 00:00

  • Secukinumab shows Higher Symptomatic improvement Versus Etanercept in Psoriatic Arthritis- Comparative Effectiveness Up To 24 Weeks Assessed by Matching-Adjusted Indirect Comparison

    Oct 1, 2017, 00:00

  • Measuring The Impact Of The Food And Drug Administration (Fda) Unapproved Drug Initiative (Udi) On Drug Prices And Expenditures

    Oct 1, 2017, 00:00

  • Which Information Sources Should Be Used To Identify Studies for Systematic Reviews of Economic Evaluations In Healthcare?

    Oct 1, 2017, 00:00

  • Economic Benefits of SFLT-1/PLGF Testing for Preeclampsia in Colombia- A Fiver Year Budget Impact Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of High-Throughput, Non-Invasive Prenatal Testing For Fetal Rhesus D Status

    Oct 1, 2017, 00:00

  • Exenatide In Obese Or Overweight Patients Without Diabetes- A Systematic Review And Meta-Analyses Of Randomized Controlled Trials

    Oct 1, 2017, 00:00

  • Determinantes Do Atraso Escolar E DA Obesidade NOS Adolescentes Brasileiros (2012 E 2015)

    Oct 1, 2017, 00:00

  • Psoriasis (PSO) Patients’ Profile And Impact of The Disease on Patients’ Quality of Life and Work Productivity In A Real-Life Setting In Brazil

    Oct 1, 2017, 00:00

  • Delayed Biologic Switching Among Psoriatic Arthritis (Psa) Patients May Result in Poor Health-Related Quality of Life- Results From A Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Cross-Cultural Adaptation And Validation Of The PEDSQL Cardiac Module Version 3.0

    Oct 1, 2017, 00:00

  • Diabetes Mellitus Self-Management Interventions in Latino Adults in the United States - The Role of Pharmacists

    Oct 1, 2017, 00:00

  • Burden of Illness Associated With Anaemia In Chronic Kidney Disease In Japan- A Literature Review

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Biological Therapies In Psoriasis Using Real World Evidence

    Oct 1, 2017, 00:00

  • What's the Reality of Real-World Evidence in Health Technology Appraisal?

    Oct 1, 2017, 00:00

  • An Introductive Analysis of the Timeframe from European Drugs Approval to the Sicilian Hospital Formulary Inclusion

    Oct 1, 2017, 00:00

  • Representing Uncertainty In Economic Evaluations- Getting More From PSA Results

    Oct 1, 2017, 00:00

  • Management Of Healthcare Priorities By Single Natural Resource Driven Economies In Emerging Markets During Commodity Price Fluctuations

    Oct 1, 2017, 00:00

  • Evaluating Physicians’ Perception Of Limitations And Obstacles Against The Effectiveness Of “Audit And Feedback” And “Printed Educational Materials” Interventions On Prescribing Behavior- A Qualitative Study

    Oct 1, 2017, 00:00

  • Knowledge And Attitudes About Ebola Virus Among Community Residents In The US- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Reporting Quality Transparency Of Published Network Meta-analysis. Is it Satisfactory?

    Oct 1, 2017, 00:00

  • Addressing Uncertainty In Wound Management Using A Modified Delphi Methodology

    Oct 1, 2017, 00:00

  • Cost-Utility Of Liquid Chromatography -Tandem Mass Spectrometry (LC-MS/MS)-Based Urine Analyses To Improve Adherence To Antihypertensive Treatment

    Oct 1, 2017, 00:00

  • Efficacy And Safety Outcomes of Recanalization Procedures In Patients with Acute Symptomatic Pulmonary Embolism- Systematic Review And Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Hepatitis C Virus- Determinants Of Patients’ Management Costs

    Oct 1, 2017, 00:00

  • Bleeding-Related Episodes (BRE) in Patients With Immune Thrombocytopenia (ITP) Receiving Eltrombopag (EPAG) or Romiplostim (ROMI)- Real World Evidence from 26 US Institutions

    Oct 1, 2017, 00:00

  • Treatment Switching and Power of ITT and RPSFTM

    Oct 1, 2017, 00:00

  • Effectiveness Of Osteoporosis Drugs In Preventing Secondary Hip Fractures In Women On Dialysis

    Oct 1, 2017, 00:00

  • European Study on Acute Cough in Children- Results of Poland

    Oct 1, 2017, 00:00

  • Α Systematic Review of Economic Evaluations of Biological Therapies for the Treatment of Ulcerative Colitis

    Oct 1, 2017, 00:00

  • Economic Burden of Cardiovascular Disease In Type 2 Diabetes- A Systematic Review

    Oct 1, 2017, 00:00

  • Effectiveness of The Peripherally Inserted Central Venous Catheter in Adult and Pediatric Patients

    Oct 1, 2017, 00:00

  • Comorbidities in Multiple Sclerosis- A Descriptive Longitudinal Clustering Analysis of Healthcare Resource Utilization Among MS Patients in IBM Explorys Database

    Oct 1, 2017, 00:00

  • Cost Implications Of Tedizolid Introduction For The Treatment Of Complicated Skin And Soft Tissue Infections In A Russian Multi-Field Hospital

    Oct 1, 2017, 00:00

  • Análise De Custo Minimização Na Substituição De Infliximabe Por Seu Biossimilar No Sistema De Saúde Suplementar Brasileiro

    Oct 1, 2017, 00:00

  • Real-World Resource Use And Costs Of Treating Controlled And Uncontrolled Carcinoid Syndrome- A Retrospective Swedish Study

    Oct 1, 2017, 00:00

  • Federal Spending on Infliximab in Brazil- An Analysis of Purchases from 2007-2015

    Oct 1, 2017, 00:00

  • Tocilizumab after A First-Line with Anti-Tnf in Rheumatoid Arthritis- A Cost-Consequence Analysis in the Italian Setting

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Ziprasidone Use In The Treatment of Schizophrenia In Russia

    Oct 1, 2017, 00:00

  • Real-World Patient Characteristics And Patterns Of Care Among Metastatic Urothelial, Head And Neck, Non-Small Cell Lung Cancer Patients Using A German Sickness Fund Claims Database

    Oct 1, 2017, 00:00

  • Rotavirus Vaccination May Reduce Acute Gastroenteritis Rates Across All Age Groups In England

    Oct 1, 2017, 00:00

  • Utilization Patterns of Lipid-Lowering Therapies in Patients at High Risk for or with Atherosclerotic Cardiovascular Disease- A Population-Based Study in South Korea

    Oct 1, 2017, 00:00

  • Facilitators and Barriers to Adult Vaccination in South East Asia and Latin America

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of Exemestane Versus Capecitabine Monotherapy for Patients with Hormone Receptor–Positive and Her2-Negative, Metastatic Breast Cancer from National Cancer Institute Prespective in Egypt

    Oct 1, 2017, 00:00

  • National Adoption of New Immunossupresants for Solid Organs and Stem Cells Transplantations

    Oct 1, 2017, 00:00

  • Comparison Of Previous IPHA-HSE Agreement Effects On The Hta Assessment Process In Ireland (2009 – 2016)

    Oct 1, 2017, 00:00

  • Ixekizumab Treatment Leads to Early Improvements in Health-Related Quality of Life Versus Ustekinumab

    Oct 1, 2017, 00:00

  • Analysis of The Individual Economic Burden (BORNE-COST BY THE PATIENTS) In Adult Patients With Atopic Dermatitis

    Oct 1, 2017, 00:00

  • Reporting Clinical Outcomes In Tavi Registries

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Analysis of A Physician-Implemented, Medication Screening Tool in Older Hospitalised Patients in Ireland

    Oct 1, 2017, 00:00

  • Current Situation And Development Of Chronic Diseases In China

    Oct 1, 2017, 00:00

  • IMPACT OF WEIGHT LOSS (WL) ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) AMONG LATIN AMERICAN (LA) SUBJECTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN PHASE 3 STUDIES OF CANAGLIFLOZIN (CANA)

    Oct 1, 2017, 00:00

  • Functional Assessment After Treatment Of Upper Extremity Soft Tissue Sarcomas Using Structured Outcome Measures- A Systematic Review

    Oct 1, 2017, 00:00

  • Assessing The Burden of Disease In Peripheral And Axial Spondyloarthritis In Mexico

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Radiofrequency Catheter Ablation Of Atrial Fibrillation Based On Real-World Data- Manual Or Robotic?”

    Oct 1, 2017, 00:00

  • Early Economic Evaluation of The New Atypical Antipsychotic

    Oct 1, 2017, 00:00

  • Regional Policies Impact on Biosimilar Adoption For Autoimmune Diseases In Italy

    Oct 1, 2017, 00:00

  • New European Medical Device Directive (MDD) Comes Into Effect In 2020- Chances And Consequences For Stakeholders

    Oct 1, 2017, 00:00

  • The Practical Application of a Digital Therapeutic Education Platform for Cardiovascular Rehabilitation

    Oct 1, 2017, 00:00

  • A Trend Towards Increased Use Of Patient Access Schemes (PAS) To Gain UK Reimbursement

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Posaconazole Versus Fluconazole in The Prophylaxis of Invasive Fungal Infections in Acute Leukemia Patients in Colombia

    Oct 1, 2017, 00:00

  • Survival Rates In Primary Hepatic Carcinoma Patients With Cirrhosis In South Korea- A Retrospective Analysis of 68,328 Patients In The National Cancer Registry

    Oct 1, 2017, 00:00

  • Use of Thalidomide In Erythematosus Lupus Treatment

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis Of Rosuvastatin Compared To Atorvastatin In Primary Prevention Of Myocardial Infarction Among HIV-Positive Patients On Haart In Uganda

    Oct 1, 2017, 00:00

  • Direct Costs of Long-Term Psychiatric Hospitalization in Public Hospital of the State of Sao Paulo, Brazil- The Complexo Hospitalar Juquery Case

    Oct 1, 2017, 00:00

  • A Sistematic Review Of The Cost-Effectiveness Of Vaccinating Elderly With The 23-Valent Pneumococcal Polysaccharide Vaccine (Ppv23)

    Oct 1, 2017, 00:00

  • Cost-Utility of Idelalisib In Combination with Rituximab In Relapsed or Refractory Chronic Lymphocytic Leukemia

    Oct 1, 2017, 00:00

  • The Traditional Ethnobotanical Knowledge Applied in Parasitology in the Andean Cordillera of Ecuador

    Oct 1, 2017, 00:00

  • Mapping Acroqol Scores to EQ-5D to Obtain Utility Values for Patients with Acromegaly

    Oct 1, 2017, 00:00

  • Allowing Methadone’s Prescription To General Practitioners- A Positive Impact on The French Healthcare Insurance Expenditures

    Oct 1, 2017, 00:00

  • Current and Potential Future Changes In The Methodology of Emerging Value Frameworks

    Oct 1, 2017, 00:00

  • Avoiding A Market For Lemons With Pharmaceuticals- How Risk-Sharing Mechanisms Can Improve Allocation

    Oct 1, 2017, 00:00

  • Exploring The Efficacy And Safety of Radiofrequency Ablation In Patients With Spinal Metastases- A Systematic Review

    Oct 1, 2017, 00:00

  • A Predictive Tool For Characterizing And Visualizing Populations Under Counterfactual Treatment Assignment

    Oct 1, 2017, 00:00

  • Variation In Health Technology Assessment And Reimbursement Decisions In England, France, And Germany- Spotlight On The Impact Of Uncertainty

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Cerebral Oximetry Monitoring In Carotid Endarterectomy- The Emocar Randomized Controlled Trial (May 2011 - April 2016)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Dabigatran with Real World Effectiveness Evidence

    Oct 1, 2017, 00:00

  • Financial Consequences of The Performance of A Pd-L1 Test To Select Patients Receiving Second and Third Line Treatments for Non-Small Cell Lung Cancer in Italy

    Oct 1, 2017, 00:00

  • Estimating Long-Term Survival in the Face of Immature Data- A Case Study of Nivolumab in Second Line Renal Cell Carcinoma

    Oct 1, 2017, 00:00

  • Estudo De Custos Da Leishmaniose Visceral No Brasil

    Oct 1, 2017, 00:00

  • Comparison Of Costs And Care Of Lung Cancer Patient At The End-Of-Life In Germany Depending On The Time Of Survival After Diagnosis

    Oct 1, 2017, 00:00

  • Impact of Golimumab, An Anti-Tnfα Monoclonal Antibody, On Health Related Quality of Life (Hrqol) And Work Productivity In Patients With Active Psoriatic Arthritis- 24-Week Results of The Phase Iii Go Vibrant Trial

    Oct 1, 2017, 00:00

  • Treatment Of Patients With Rheumatoid Arthritis- Real World Population-Based Evidence From France

    Oct 1, 2017, 00:00

  • Burden of High Disease Activity in Systemic Lupus Erythematosus (SLE)- Results of A Targeted Literature Review

    Oct 1, 2017, 00:00

  • Horizon Scanning In Oncology – Rapid Scanning Approach In Slovakia

    Oct 1, 2017, 00:00

  • Economic Evaluation For Establishing Stroke Unit Followed By Early Supported Discharge In Egypt

    Oct 1, 2017, 00:00

  • Economic Evaluation of Abiraterone in Metastatic Castration-Resistant Prostate Cancer in Patients With None/Mild Symptoms After Failure of Androgen Deprivation Therapy

    Oct 1, 2017, 00:00

  • The Cost Effectiveness of Oxycodone In Patients Who Do Not Respond To Morphine From The Brazilian Public Health System Perspective

    Oct 1, 2017, 00:00

  • Direct Costs of Health Care of Cystic Fibrosis, The Case of A Health Insurer In Colombia

    Oct 1, 2017, 00:00

  • A Quality-Adjusted Time without Symptoms of Disease And Toxicity (Q-TWIST) Analysis Comparing Nivolumab and Therapy Of Investigator’s Choice (IC) in Patients with Recurrent or Metastatic (R/M) Platinum-Refractory Squamous Cell Carcinoma of ...

    Oct 1, 2017, 00:00

  • Assessment of Economic Model Stability By Repeated One-Way Sensitivity Analysis

    Oct 1, 2017, 00:00

  • Market Dynamics of Statin Medications

    Oct 1, 2017, 00:00

  • Real World Data Analysis of Type 2 Diabetes Mellitus Treatment In An Integrated Health District

    Oct 1, 2017, 00:00

  • The Economic Burden of Chronic Obstructive Pulmonary Disease In The Spanish Region of Extremadura

    Oct 1, 2017, 00:00

  • Knowledge And Confidence Of Healthcare Providers Working At Hospitals About Appropriate Prescribing For Geriatrics

    Oct 1, 2017, 00:00

  • Review of Surrogate Endpoint Validation Methodologies and Application In Solid Tumour Htas

    Oct 1, 2017, 00:00

  • Comparative Effectiveness And Medical Cost of Dabigatran Versus Vitamin K Antagonists From Engel 2- A French Nationwide Cohort Of 100,000 Patients With Non-Valvular Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Health Economics And Outcomes Research Needs Assessment For Latin America- Relationship Between Perceived And Expected Quality Of Knowledge In A Self-Assessment Survey

    Oct 1, 2017, 00:00

  • Treatment interruption of Biological Drugs in Rheumatoid Arthritis- An Assessment of Case-Reports

    Oct 1, 2017, 00:00

  • The Burden of Spondyloarthritis – Paasport A Population-Based Study

    Oct 1, 2017, 00:00

  • First-Line Pembrolizumab in PD-L1 Positive Non-Small Cell Lung Cancer- A Cost-Effectiveness Analysis from A UK Healthcare Perspective

    Oct 1, 2017, 00:00

  • Antihypertensive Drug Prescription Patterns and their Impact on Outcome of Blood Pressure in Ethiopia-A Hospital-Based Observational Study

    Oct 1, 2017, 00:00

  • Treatment Satisfaction Among Patients with Moderate-to-Severe Plaque Psoriasis in Brazil

    Oct 1, 2017, 00:00

  • Substantiation of the National Policy of Pricing and Availability of Drugs

    Oct 1, 2017, 00:00

  • Do Countries With Similar GDPS And Health Expenditures Reimburse The Same Cancer Drugs?

    Oct 1, 2017, 00:00

  • Value Of A Pilot Study In A Retrospective Chart Review- Final Protocol Design Should Base On Pilot Results

    Oct 1, 2017, 00:00

  • Caracterización Del Riesgo Cardiovascular Por Factores Asociados- Análisis De Base De Datos De UNA Aseguradora Colombiana

    Oct 1, 2017, 00:00

  • Minimally Important Differen Empirical Comparison Of Estimation Methods Using Orthopaedics And Otolaryngology

    Oct 1, 2017, 00:00

  • Analysis of Consumption of Anti-TB Medicines in Ukraine During 2012-2016

    Oct 1, 2017, 00:00

  • Challenges in Optimising Real World Evidence for Alzheimer’s Disease

    Oct 1, 2017, 00:00

  • Judicialização Da Saúde No Brasil- Proximidade Dos Magistrados Com As Políticas Públicas De Saúde

    Oct 1, 2017, 00:00

  • Development Of A Tool To Quantify An Individual’s History Of Sun Exposure- Qualitative Phase Of The Development Of The Sun Exposure Questionnaire

    Oct 1, 2017, 00:00

  • Analysing Uptake Of New Medicine Service In English Community Pharmacies

    Oct 1, 2017, 00:00

  • Economic Impact of Alirocumab In The Management of Primary Hypercholesterolemia or Mixed Dyslipidemia- An Italian Perspective

    Oct 1, 2017, 00:00

  • The Effect Of Chronic Diseases, Financial Hardship And Personality Types In Patient's Medication Adherence

    Oct 1, 2017, 00:00

  • Value Of Treating All Liver Fibrosis Stages To Reach Elimination Of Diagnosed Chronic Hepatitis C- A Modelling Approach In France

    Oct 1, 2017, 00:00

  • Hospital Burden 18 Months after Surgical Treatment of Functional Menorrhagia in France

    Oct 1, 2017, 00:00

  • Loss Of Response Of Anti TNF-Α Agents As The Second-Line Therapy In Inflammatory Bowel Disease- Based On Korean National Insurnance Claims Data

    Oct 1, 2017, 00:00

  • Applying Nice End Of Life Criteria In The ERA Of Drug Approvals Based On Single-ARM Trial Data

    Oct 1, 2017, 00:00

  • Health Technology Assessment Decisions in Immuno-Oncology Therapies- Results, Rationales, and Trends

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analysis of Enzalutamide and Abiraterone for Treatment of Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer

    Oct 1, 2017, 00:00

  • Comparison of The Long-Term Cost-Effectiveness of Ideglira Versus Multiple Daily Insulin Injections In The Spanish Setting Using Real-World Clinical Data

    Oct 1, 2017, 00:00

  • Cost of Ilness Analysis- A Comparison of The Costs of Drug Therapy for Patients with Prostate Cancer, Breast Cancer, Colon Cancer, Melanoma and Renal Cell Carcinoma in Moscow

    Oct 1, 2017, 00:00

  • Switching Maintenance Infliximab Therapy to Biosimilar-Infliximab does Not Lead to Significant Changes in Health-Related Quality of Life and Clinical Outcomes in Inflammatory Bowel Disease Patients

    Oct 1, 2017, 00:00

  • HTA MCDA In The Treatment of Macular Edema

    Oct 1, 2017, 00:00

  • Initiative To Obtain Advanced Therapeutic Outcomes In Multiple Myeloma (Importa Project)

    Oct 1, 2017, 00:00

  • Predictors Of Activity And Participation In People With Motor Neurone Disease, Multiple Sclerosis And Parkinson’s Disease

    Oct 1, 2017, 00:00

  • Minimizing Bias In Indirect Comparisons Utilizing Virtual Patient Level Data

    Oct 1, 2017, 00:00

  • Modelling the Societal Impact of Secukinumab in Patients with Psoriatic Arthritis in Germany

    Oct 1, 2017, 00:00
  • «
  • 71
  • 72
  • 73
  • 74 (current)
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »